Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2023

Open Access 01-12-2023 | Acupuncture | Case Report

Ayurveda management of pulmonary mycosis: an integrative approach: a case report

Authors: Prasan Shankar, Bhavya Vijay, Narendra Pendse, Mahima Rahman, Vasudevan Nampoothiri

Published in: Journal of Medical Case Reports | Issue 1/2023

Login to get access

Abstract

Background

Pulmonary mycosis is a fungal infection of the lung. Antifungal treatments are used in conventional treatments; however, incomplete response and toxicity are major challenges of antifungal therapies. In Ayurveda, pulmonary mycosis is diagnosed and treated based on principles of respiratory disorders (referred to as Shvaas Roga) with promising outcomes.

Case presentation

A > 60-year-old South Indian male patient visited Institute of Ayurveda and Integrative Medicine with complaints of cough, breathlessness, pedal edema, weight loss, uncontrolled diabetes, and anemia. Following chest X-ray, high-resolution computed tomography (HRCT) and bronchoscopy, the patient was diagnosed with a case of pulmonary mucormycosis. The patient had availed conventional allopathic treatment for 3 months including standard antifungal medication for 3 weeks. However, due to unresolved and persistent symptoms, the patient sought Ayurveda treatment. The patient was diagnosed and treated for 6 weeks as a case of Shvaasa Roga, a subcategory of the respiratory disorder according to Ayurveda, and was cured of the infection following an integrative Ayurveda management regime which included internal medicines, panchakarma, necessary poorvakarmas (like abhyanga and swedhana), diet and lifestyle advice, yoga and acupuncture.

Conclusions

The patient was cured of fungal lung infection in 6 weeks using an integrative approach. Primary Ayurveda treatment supported with diet and lifestyle modifications, yoga, and acupuncture helped the patient to recover from illness. The patient is alive and free of disease for more than one year to date.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bellmann R, Bellmann-Weiler R, Weiler S. Pulmonary mycoses. Mag Eur. Med Oncol. 2008;1:15–9. Bellmann R, Bellmann-Weiler R, Weiler S. Pulmonary mycoses. Mag Eur. Med Oncol. 2008;1:15–9.
2.
go back to reference Muthu V, Agarwal R, Dhooria S, Sehgal IS, Prasad KT, Aggarwal AN, et al. Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis. Clin Microbiol Infect. 2021;27:538–49.CrossRef Muthu V, Agarwal R, Dhooria S, Sehgal IS, Prasad KT, Aggarwal AN, et al. Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis. Clin Microbiol Infect. 2021;27:538–49.CrossRef
3.
go back to reference Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021;9:523.CrossRef Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021;9:523.CrossRef
4.
go back to reference Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH. Amphotericin B: time for a new “gold standard.” Clin Infect Dis. 2003;37:415–25.CrossRef Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH. Amphotericin B: time for a new “gold standard.” Clin Infect Dis. 2003;37:415–25.CrossRef
6.
go back to reference White PL, Dhillon R, Hughes H, Wise MP, Backx M. COVID-19 and fungal infection: the need for a strategic approach. Lancet Microbe. 2020;1: e196.CrossRef White PL, Dhillon R, Hughes H, Wise MP, Backx M. COVID-19 and fungal infection: the need for a strategic approach. Lancet Microbe. 2020;1: e196.CrossRef
7.
go back to reference Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16:1708–17.CrossRef Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16:1708–17.CrossRef
8.
go back to reference Scorzoni L, Silva ACADP, Marcos CM, Assato PA, de Melo WCMA, de Oliveira HC, et al. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol. 2017;8:36. Scorzoni L, Silva ACADP, Marcos CM, Assato PA, de Melo WCMA, de Oliveira HC, et al. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol. 2017;8:36.
9.
go back to reference Mishra KK, Kaur CD, Sahu AK, Panik R, Kashyap P, Mishra SP, et al. Medicinal plants having antifungal properties. In: Hassan BAR, editor., et al., Medicinal plants—use in prevention and treatment of diseases. London: IntechOpen; 2020. p. 97–110. Mishra KK, Kaur CD, Sahu AK, Panik R, Kashyap P, Mishra SP, et al. Medicinal plants having antifungal properties. In: Hassan BAR, editor., et al., Medicinal plants—use in prevention and treatment of diseases. London: IntechOpen; 2020. p. 97–110.
10.
go back to reference Vahedi-Shahandashti R, Lass-Flörl C. Novel antifungal agents and their activity against Aspergillus species. J Fungi (Basel). 2020;6:213.CrossRef Vahedi-Shahandashti R, Lass-Flörl C. Novel antifungal agents and their activity against Aspergillus species. J Fungi (Basel). 2020;6:213.CrossRef
11.
go back to reference Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā-Dipika. Commentary by Chakrapanidatta. Varanasi: Chaukhamba Krishnadas Academy; 2007. p. 537. Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā-Dipika. Commentary by Chakrapanidatta. Varanasi: Chaukhamba Krishnadas Academy; 2007. p. 537.
12.
go back to reference Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā. Dipika Comment by Chakrapanidatta. Varanasi: Chaukhamba Krishnadas Academy; 2007. p. 539. Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā. Dipika Comment by Chakrapanidatta. Varanasi: Chaukhamba Krishnadas Academy; 2007. p. 539.
13.
go back to reference Samal J. Ayurvedic management of pulmonary tuberculosis: a systematic review. J Intercult Ethnopharmacol. 2015;5:86–91.CrossRef Samal J. Ayurvedic management of pulmonary tuberculosis: a systematic review. J Intercult Ethnopharmacol. 2015;5:86–91.CrossRef
14.
go back to reference Vaidya MS, Shinde AP, Vaidya MA. Ayurvedic management of interstitial lung disease: a case report. The Healer J. 2021;2:126–31.CrossRef Vaidya MS, Shinde AP, Vaidya MA. Ayurvedic management of interstitial lung disease: a case report. The Healer J. 2021;2:126–31.CrossRef
15.
go back to reference Debnath PK, Chattopadhyay J, Mitra A, Adhikari A, Alam MS, Bandopadhyay SK, et al. Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis. J Ayurveda Integr Med. 2012;3:141.CrossRef Debnath PK, Chattopadhyay J, Mitra A, Adhikari A, Alam MS, Bandopadhyay SK, et al. Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis. J Ayurveda Integr Med. 2012;3:141.CrossRef
16.
go back to reference Arefin P. A review on the ayurvedic management of causes and symptoms of bronchial asthma. ASA University Review. 2015;9:269–76. Arefin P. A review on the ayurvedic management of causes and symptoms of bronchial asthma. ASA University Review. 2015;9:269–76.
17.
go back to reference Vikrant VK, Upadhyay A, Mutha R, Harshitha KS. Exploring the potential role of herbal ayurveda formulation vasadi kashaya in chronic obstructive pulmonary disease—a review. J Ayurveda Integr Med Sci. 2021;6:144–8. Vikrant VK, Upadhyay A, Mutha R, Harshitha KS. Exploring the potential role of herbal ayurveda formulation vasadi kashaya in chronic obstructive pulmonary disease—a review. J Ayurveda Integr Med Sci. 2021;6:144–8.
18.
go back to reference Paul AM, Antony A, Nu S, Hameed HY. A case report on ayurvedic medicine (red mercuric sulphate) induced bronchiolitis obliterans organizing pneumonia (Boop) in sero positive rheumatoid patient. Int J Pharm Pharm Sci. 2015;7:399–401. Paul AM, Antony A, Nu S, Hameed HY. A case report on ayurvedic medicine (red mercuric sulphate) induced bronchiolitis obliterans organizing pneumonia (Boop) in sero positive rheumatoid patient. Int J Pharm Pharm Sci. 2015;7:399–401.
19.
go back to reference Mohsina FP, Faheem IP, Tabassum S, Shah I, Ahmad A. An insight of mucormycosis (black fungus) in ayurveda. Open J Pharmacol Pharmacother. 2021;6:013–7.CrossRef Mohsina FP, Faheem IP, Tabassum S, Shah I, Ahmad A. An insight of mucormycosis (black fungus) in ayurveda. Open J Pharmacol Pharmacother. 2021;6:013–7.CrossRef
20.
go back to reference Joshi JA, Puthiyedath R. Outcomes of ayurvedic care in a COVID-19 patient with hypoxia—a case report. J Ayurveda Integr Med. 2022;13: 100363.CrossRef Joshi JA, Puthiyedath R. Outcomes of ayurvedic care in a COVID-19 patient with hypoxia—a case report. J Ayurveda Integr Med. 2022;13: 100363.CrossRef
21.
go back to reference Mishra A, Bentur SA, Thakral S, Garg R, Duggal B. The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report. J Med Case Rep. 2021;15:95.CrossRef Mishra A, Bentur SA, Thakral S, Garg R, Duggal B. The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report. J Med Case Rep. 2021;15:95.CrossRef
22.
go back to reference Adluri USP, Perugu S. Evaluation of efficacy and safety of adjuvant ayurvedic therapy in patients with severe post-covid mucor-mycosis at a government tertiary care hospital—a case-control study. J Ayurveda Integr Med. 2022;13: 100585.CrossRef Adluri USP, Perugu S. Evaluation of efficacy and safety of adjuvant ayurvedic therapy in patients with severe post-covid mucor-mycosis at a government tertiary care hospital—a case-control study. J Ayurveda Integr Med. 2022;13: 100585.CrossRef
23.
go back to reference Yu M, Gao L, Kong Y, Yan Y, Shi Q, Si D, et al. Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: a systematic review protocol. Medicine (Baltimore). 2019;98: e17112.CrossRef Yu M, Gao L, Kong Y, Yan Y, Shi Q, Si D, et al. Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: a systematic review protocol. Medicine (Baltimore). 2019;98: e17112.CrossRef
24.
go back to reference Feng J, Wang X, Li X, Zhao D, Xu J. Acupuncture for chronic obstructive pulmonary disease (COPD): a multicenter, randomized, sham-controlled trial. Medicine (Baltimore). 2016;95: e4879.CrossRef Feng J, Wang X, Li X, Zhao D, Xu J. Acupuncture for chronic obstructive pulmonary disease (COPD): a multicenter, randomized, sham-controlled trial. Medicine (Baltimore). 2016;95: e4879.CrossRef
25.
go back to reference Bhuvaneshwari S, Vishnu DS. Study of efficacy of Mebarid—an ayurvedic compound formulation in children with acute diarrhea. Int J Pharma Bio Sci. 2012;3:97–103. Bhuvaneshwari S, Vishnu DS. Study of efficacy of Mebarid—an ayurvedic compound formulation in children with acute diarrhea. Int J Pharma Bio Sci. 2012;3:97–103.
26.
go back to reference Singh N, Pande M. Comparative evaluation of quality standards for Dadimashtaka Churna: a polyherbal formulation. World J Pharm Pharm Sci. 2017;6:1556–64. Singh N, Pande M. Comparative evaluation of quality standards for Dadimashtaka Churna: a polyherbal formulation. World J Pharm Pharm Sci. 2017;6:1556–64.
27.
go back to reference Meena AK, Kaur R, Singh B, Yadav AK, Singh U, Sachan A, et al. Review on antifungal activities of Ayurvedic Medicinal Plants. Drug Invent Today. 2009;2:146–8. Meena AK, Kaur R, Singh B, Yadav AK, Singh U, Sachan A, et al. Review on antifungal activities of Ayurvedic Medicinal Plants. Drug Invent Today. 2009;2:146–8.
28.
go back to reference Kekuda TRP, Kavya R, Shrungashree RM, Suchitra SV. Screening of selected single and polyherbal ayurvedic medicines for antibacterial and antifungal activity. Anc Sci Life. 2010;29:22–5. Kekuda TRP, Kavya R, Shrungashree RM, Suchitra SV. Screening of selected single and polyherbal ayurvedic medicines for antibacterial and antifungal activity. Anc Sci Life. 2010;29:22–5.
29.
go back to reference Saokar RM, Sarashetti RS, Kanthi V, Savkar M, Nagthan CV. Screening of antibacterial and antifungal activity of gandhaka rasayana—an ayurvedic formulation. Int J Recent Trends Sci Technol. 2013;8:134–7. Saokar RM, Sarashetti RS, Kanthi V, Savkar M, Nagthan CV. Screening of antibacterial and antifungal activity of gandhaka rasayana—an ayurvedic formulation. Int J Recent Trends Sci Technol. 2013;8:134–7.
30.
go back to reference Ahmed F, Ali I, Ragunath, Jayashree, Yallappa GK. An experimental evaluation of maha nimba (Melia azadirach L.) L It’s krimighna (anti fungal) activity w.s.r to Candida albicans—Invitro study—a pilot study. Int Ayurvedic Med J. 2018;2:1343–51. Ahmed F, Ali I, Ragunath, Jayashree, Yallappa GK. An experimental evaluation of maha nimba (Melia azadirach L.) L It’s krimighna (anti fungal) activity w.s.r to Candida albicans—Invitro study—a pilot study. Int Ayurvedic Med J. 2018;2:1343–51.
31.
go back to reference Kaushik K, Agarwal S. The role of herbal antifungal agents for the management of fungal diseases: a systematic review. Asian J Pharm Clin Res. 2019;12:34–40.CrossRef Kaushik K, Agarwal S. The role of herbal antifungal agents for the management of fungal diseases: a systematic review. Asian J Pharm Clin Res. 2019;12:34–40.CrossRef
32.
go back to reference Mehmood Z, Ahmad I, Mohammad F, Ahmad S. Indian medicinal plants: a potential source for anticandidal drugs. Pharm Biol. 1999;37:237–42.CrossRef Mehmood Z, Ahmad I, Mohammad F, Ahmad S. Indian medicinal plants: a potential source for anticandidal drugs. Pharm Biol. 1999;37:237–42.CrossRef
33.
go back to reference Agrawal AK, Tripathi DM, Sahai R, Gupta N, Saxena RP, Puri A, et al. Management of giardiasis by a herbal drug “Pippali Rasayana”: a clinical study. J Ethnopharmacol. 1997;56:233–6.CrossRef Agrawal AK, Tripathi DM, Sahai R, Gupta N, Saxena RP, Puri A, et al. Management of giardiasis by a herbal drug “Pippali Rasayana”: a clinical study. J Ethnopharmacol. 1997;56:233–6.CrossRef
34.
go back to reference Kumar R, Rai J, Kajal NC, Devi P. Comparative study of effect of Withania somnifera as an adjuvant to DOTS in patients of newly diagnosed sputum smear positive pulmonary tuberculosis. Indian J Tuberc. 2018;65:246–51.CrossRef Kumar R, Rai J, Kajal NC, Devi P. Comparative study of effect of Withania somnifera as an adjuvant to DOTS in patients of newly diagnosed sputum smear positive pulmonary tuberculosis. Indian J Tuberc. 2018;65:246–51.CrossRef
35.
go back to reference Daswani PG. Non-antibiotic potential of medicinal plants to combat urinary tract infections. Curr Sci. 2019;117:1459–68.CrossRef Daswani PG. Non-antibiotic potential of medicinal plants to combat urinary tract infections. Curr Sci. 2019;117:1459–68.CrossRef
36.
go back to reference Birdi T, Daswani P, Brijesh S, Tetali P, Natu A, Antia N. Newer insights into the mechanism of action of Psidium guajava L leaves in infectious diarrhoea. BMC Complement Altern Med. 2010;10:33.CrossRef Birdi T, Daswani P, Brijesh S, Tetali P, Natu A, Antia N. Newer insights into the mechanism of action of Psidium guajava L leaves in infectious diarrhoea. BMC Complement Altern Med. 2010;10:33.CrossRef
37.
go back to reference Wanjarkhedkar P, Sarade G, Purandare B, Kelkar D. A prospective clinical study of an Ayurveda regimen in COVID 19 patients. J Ayurveda Integr Med. 2022;13: 100365.CrossRef Wanjarkhedkar P, Sarade G, Purandare B, Kelkar D. A prospective clinical study of an Ayurveda regimen in COVID 19 patients. J Ayurveda Integr Med. 2022;13: 100365.CrossRef
38.
go back to reference Acharya JT. Chakrapanidatta. CarakaSamhita of Agnivesa with Āyurvedā-Dipika Ch 17/ 17. Varanasi: Chaukhambha Orientalia; 2011. Acharya JT. Chakrapanidatta. CarakaSamhita of Agnivesa with Āyurvedā-Dipika Ch 17/ 17. Varanasi: Chaukhambha Orientalia; 2011.
39.
go back to reference Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā-Dipika commentary by commentary. Varanasi: Chaukhambha Orientalia; 2007. p. 147–8. Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā-Dipika commentary by commentary. Varanasi: Chaukhambha Orientalia; 2007. p. 147–8.
40.
go back to reference Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā-Dipika commentary by Chakrapanidatta. Varanasi: Chaukhambha Surabharati Prakashan; 2011. p. 21. Acharya JT. Caraka Samhita of Agnivesa with Āyurvedā-Dipika commentary by Chakrapanidatta. Varanasi: Chaukhambha Surabharati Prakashan; 2011. p. 21.
41.
go back to reference Parekar RR, Bolegave SS, Marathe PA, Rege NN. Experimental evaluation of analgesic, anti-inflammatory and anti-platelet potential of Dashamoola. J Ayurveda Integr Med. 2015;6:11–8.CrossRef Parekar RR, Bolegave SS, Marathe PA, Rege NN. Experimental evaluation of analgesic, anti-inflammatory and anti-platelet potential of Dashamoola. J Ayurveda Integr Med. 2015;6:11–8.CrossRef
42.
go back to reference Kumar S, Malhotra S, Prasad AK, van der Eycken EV, Bracke ME, Stetler-Stevenson WG, et al. Anti-inflammatory and antioxidant properties of Piper species: a perspective from screening to molecular mechanisms. Curr Top Med Chem. 2015;15:886–93.CrossRef Kumar S, Malhotra S, Prasad AK, van der Eycken EV, Bracke ME, Stetler-Stevenson WG, et al. Anti-inflammatory and antioxidant properties of Piper species: a perspective from screening to molecular mechanisms. Curr Top Med Chem. 2015;15:886–93.CrossRef
43.
go back to reference Shariatpanahi ZV, Taleban FA, Mokhtari M, Shahbazi S. Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit. J Crit Care. 2010;25:647–50.CrossRef Shariatpanahi ZV, Taleban FA, Mokhtari M, Shahbazi S. Ginger extract reduces delayed gastric emptying and nosocomial pneumonia in adult respiratory distress syndrome patients hospitalized in an intensive care unit. J Crit Care. 2010;25:647–50.CrossRef
44.
go back to reference Yocum GT, Hwang JJ, Mikami M, Danielsson J, Kuforiji AS, Emala CW. Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model. Am J Physiol Lung Cell Mol Physiol. 2020;318:L296–303.CrossRef Yocum GT, Hwang JJ, Mikami M, Danielsson J, Kuforiji AS, Emala CW. Ginger and its bioactive component 6-shogaol mitigate lung inflammation in a murine asthma model. Am J Physiol Lung Cell Mol Physiol. 2020;318:L296–303.CrossRef
45.
go back to reference Salva S, Villena J, Alvarez S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections. Int J Food Microbiol. 2010;141:82–9.CrossRef Salva S, Villena J, Alvarez S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections. Int J Food Microbiol. 2010;141:82–9.CrossRef
46.
go back to reference Jamil S, Jabeen A, Ahmad S. Pulmonary tuberculosis and its management in classical Unani literature. Indian J Tradit Knowl. 2005;4:143–9. Jamil S, Jabeen A, Ahmad S. Pulmonary tuberculosis and its management in classical Unani literature. Indian J Tradit Knowl. 2005;4:143–9.
47.
go back to reference Lim SMS, Sinnollareddy M, Sime FB. Challenges in antifungal therapy in diabetes mellitus. J Clin Med. 2020;9:2878.CrossRef Lim SMS, Sinnollareddy M, Sime FB. Challenges in antifungal therapy in diabetes mellitus. J Clin Med. 2020;9:2878.CrossRef
48.
go back to reference Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019;8:76.CrossRef Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019;8:76.CrossRef
49.
go back to reference Bremenkamp RM, Caris AR, Jorge AOC, Back-Brito GN, Mota AJ, Balducci I, et al. Prevalence and antifungal resistance profile of Candida spp oral isolates from patients with type 1 and 2 diabetes mellitus. Arch Oral Biol. 2011;56:549–55.CrossRef Bremenkamp RM, Caris AR, Jorge AOC, Back-Brito GN, Mota AJ, Balducci I, et al. Prevalence and antifungal resistance profile of Candida spp oral isolates from patients with type 1 and 2 diabetes mellitus. Arch Oral Biol. 2011;56:549–55.CrossRef
50.
go back to reference Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16:S27-36.CrossRef Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16:S27-36.CrossRef
51.
go back to reference Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–65.CrossRef Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–65.CrossRef
52.
go back to reference Pérez JC. Fungi of the human gut microbiota: roles and significance. Int J Med Microbiol. 2021;311: 151490.CrossRef Pérez JC. Fungi of the human gut microbiota: roles and significance. Int J Med Microbiol. 2021;311: 151490.CrossRef
53.
go back to reference Mukta RMV, Arora J. Efficacy of Samsarjanakrama in a patient with Agnimandya due to Vyadhi Sankar: a case study. J Ayurveda Integr Med. 2021;12:182–6.CrossRef Mukta RMV, Arora J. Efficacy of Samsarjanakrama in a patient with Agnimandya due to Vyadhi Sankar: a case study. J Ayurveda Integr Med. 2021;12:182–6.CrossRef
55.
go back to reference Arpan AB, Shweta P, Brajesh S, Gauravi V, Gyanendra DS, Upasna G. The role of yoga therapy in the management of bronchial asthma (Tamaka Shwasa). Asian J Pharm Clin Res. 2019;12:27–33.CrossRef Arpan AB, Shweta P, Brajesh S, Gauravi V, Gyanendra DS, Upasna G. The role of yoga therapy in the management of bronchial asthma (Tamaka Shwasa). Asian J Pharm Clin Res. 2019;12:27–33.CrossRef
56.
go back to reference Nagarathna R, Nagendra HR, Majumdar V. A perspective on yoga as a preventive strategy for coronavirus disease 2019. Int J Yoga. 2020;13:89–98.CrossRef Nagarathna R, Nagendra HR, Majumdar V. A perspective on yoga as a preventive strategy for coronavirus disease 2019. Int J Yoga. 2020;13:89–98.CrossRef
Metadata
Title
Ayurveda management of pulmonary mycosis: an integrative approach: a case report
Authors
Prasan Shankar
Bhavya Vijay
Narendra Pendse
Mahima Rahman
Vasudevan Nampoothiri
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Acupuncture
Published in
Journal of Medical Case Reports / Issue 1/2023
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03736-6

Other articles of this Issue 1/2023

Journal of Medical Case Reports 1/2023 Go to the issue